Personal Information
Entreprise/Lieu de travail
Greater New York City Area United States
Profession
Owner Michael Ibara LLC
Secteur d’activité
Medical / Health Care / Pharmaceuticals
Site Web
about.me/michael.ibara/
À propos
Healthcare executive with broad experience in all aspects of drug development, safety surveillance and management, with direct experience in applications to digital healthcare.
Specific interests: Digital Healthcare; data standards; pharmacovigilance
Mots-clés
pharmacovigilance
drug safety
safety
aster
esource
clinical trials
pharmaceutical
social media
healthcare
fda
socialmedia pharmacovigilance social media
learning healthcare system
interoperability
biopharmaceutical
analytics
regulations
regulatory
cdisc
public health
china
Tout plus
Présentations
(12)J’aime
(6)Notes from Coursera Deep Learning courses by Andrew Ng
Tess Ferrandez
•
il y a 6 ans
CME and Social Media
Lee Aase
•
il y a 13 ans
FDA Presentation: How Marketers Should Manage Online Adverse Event Reporting
Ogilvy PR 360 Digital Influence Pharma
•
il y a 14 ans
Five Questions About Social Media and Pharma
GSW
•
il y a 14 ans
Dose of Digital FDA Pharma Social Media Hearing Testimony - Adverse Event Reporting
Jonathan Richman
•
il y a 14 ans
Healthcare Napkins All
Dan Roam
•
il y a 14 ans
Personal Information
Entreprise/Lieu de travail
Greater New York City Area United States
Profession
Owner Michael Ibara LLC
Secteur d’activité
Medical / Health Care / Pharmaceuticals
Site Web
about.me/michael.ibara/
À propos
Healthcare executive with broad experience in all aspects of drug development, safety surveillance and management, with direct experience in applications to digital healthcare.
Specific interests: Digital Healthcare; data standards; pharmacovigilance
Mots-clés
pharmacovigilance
drug safety
safety
aster
esource
clinical trials
pharmaceutical
social media
healthcare
fda
socialmedia pharmacovigilance social media
learning healthcare system
interoperability
biopharmaceutical
analytics
regulations
regulatory
cdisc
public health
china
Tout plus